Biosyntia
Business Services · Denmark · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Copenhagen Ø DK-2100, Copenhagen, South ...Phone Number
+45 23802329Website
www.biosyntia.comRevenue
<$5 MillionIndustry
About Biosyntia
Is Biosyntia your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Biosyntia has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Biosyntia has new funding data
Click to see if Biosyntia had a recent Job posting/layoffs
Earning: See what the market has to say on Biosyntia recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Biosyntia
Website visits: Recent activity has been detected on your website
Check out if Biosyntia is spiking on competitors!
Biosyntia, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Biosyntia launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Biosyntia is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Biosyntia is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Biosyntia.
Biosyntia financials insights
Gather financial insights about Biosyntia, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Angel/Seed
$1.9M
Other Financing Round
$11.7M
Biosyntia Tech Stack
A closer look at the technologies used by Biosyntia
Most Recent Scoops
Biosyntia News & Media
Biosyntia closes a €11.5m Series B round, backed by ECBF
Biosyntia closes a €11.5m Series B round, backed by ECBF Submitted 06/07/2022 - 5:03pm Biosyntia has closed a Series B funding round of €11.5 million from a strong syndicate of experienced venture capital investors. The round was closed with an investment from the European Circular Bioeconomy Fund (ECBF) and the two existing investors, Sofinnova Partners and Novo Seeds, the early-stage investment and company creation team of Novo Holdings A/S. The investment will allow the company
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Biosyntia
Biosyntia is an industrial biotech company developing bio-based manufacturing processes with core capabilities within strain engineering and fermentation. The company was founded in 2012 by Hans Genee, Andreas Lausten and serial entrepreneur, DTU Professor Morten Sommer. Biosyntia develops microbes and processes at an unprecedented speed and effici... Read More